Author:
Krishnamurthy Kritika,Chai Jiani,Liu Xiaowei,Elsayad Mahmoud,Goldstein Doctor Y.
Reference34 articles.
1. Myers D.J., Wallen J.M.. Lung Adenocarcinoma. 2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–.
2. Targeted therapy for patients with metastatic non-small cell lung cancer;Reckamp;J. Natl. ComprCancNetw,2018
3. Ettinger D.S., Wood D.E., Aisner D.L., Akerley W., Bauman J.R., Bharat A., Bruno D.S., Chang J.Y., Chirieac L.R., D'Amico T.A., Dilling T.J., Dowell J., Gettinger S., Gubens M.A., Hegde A., Hennon M., Lackner R.P., Lanuti M., Leal T.A., Lin J., Loo B.W. Jr, Lovly C.M., Martins R.G., Massarelli E., Morgensztern D., Ng T., Otterson G.A., Patel S.P., Riely G.J., Schild S.E., Shapiro T.A., Singh A.P., Stevenson J., Tam A., Yanagawa J., Yang S.C., Gregory K.M., Hughes M. NCCN guidelines insights: non-small cell lung cancer, Version 2.2021. J. Natl. Compr. Canc. Netw. 2021;19(3):254-266.
4. Correlation of histologic subtypes and molecular alterations in pulmonary adenocarcinoma: therapeutic and prognostic implications;Kim;Adv. Anat. Pathol.,2016
5. The underlying tumor genomics of predominant histologic subtypes in lung adenocarcinoma;Caso;J. Thorac. Oncol.,2020